During this exclusive on-the-record briefing for reporters, Robert M. Califf, M.D., Commissioner of Food and Drugs for the U.S. Food and Drug Administration, participated in a fireside chat with Sarah J. Dash, President and CEO of the Alliance for Health Policy, and respond to audience questions.
This event outlined the various coverage-related elements at play over the next six to nine months, their tradeoffs, and how they may impact various stakeholders, including consumers, state leaders, and payers.
During this session, panelists provided an overview of the role of the FDA particularly focusing on the approval process required to bring new medical products to market.
During this exclusive briefing, former CMS Administrators Nancy Ann-DeParle and Dr. Mark McClellan provided a forward-thinking perspective about the implications of policy changes to the Medicare program.
During this session, panelists provided an overview of home and community-based services, including populations receiving these services, current enrollment numbers, workforce challenges, benefits of HCBS, and barriers to caring for complex populations.
The Summit on Mental Health in America will feature industry visionaries, administration executives, and a host of experts to discuss topic areas such as equitable inclusion, innovation, and workforce capacities.
During this session, panelists reviewed the basic mechanisms of the Medicare program, with specific focus on traditional Medicare (Parts A and B) and Medicare Advantage (Part C).
This session provided insight into the Medicare population, enrollment trends, and affordability considerations for beneficiaries in traditional Medicare and Medicare Advantage.
This session helped attendees consider the implications of policy options to promote Medicare sustainability. Panelists explored trends in Medicare spending; introduced key concepts related to Medicare financing and solvency; and explored the implications of policy options to promote Medicare sustainability.
This event helped the audience understand the current policy landscape shaping Medicare and Medicaid programs as well as principles of person- and community-centered care. Speakers discussed lessons learned from the PHE, including insights from recent research and on-the-ground experts, and highlighted policy levers available to state and federal policymakers to build upon these current flexibilities.
This event highlighted current trends in enrollment, premiums, and out-of-pocket costs in private insurance markets, and presented challenges and opportunities in getting eligible consumers enrolled in appropriate coverage. Panelists also explored coverage affordability and enrollment levers, including potential policy actions at federal and state levels.
This event explained user fee programs and their role within the drug development and FDA regulatory review process. Panelists provided insights on the stakeholders, timeline, the process of reauthorization, the history of these bills being used for broader health legislative initiatives, and explored lessons learned.
This briefing provided a round-up of state-level policies enacted during the past few years that are focused on cost containment, complex care, and drug pricing reform. Panelists overviewed health policies implemented and evaluated at the state level, synthesize major lessons and takeaways from these policies, and highlighted states or programs to watch in 2022.
This event explored health policy milestones from the past year and their potential impact on 2022. Panelists offered a high-level analysis of the policies that Congress and the administration have pursued to date, potential implementation opportunities and challenges, as well as current health-related court cases.
Voices from the Frontlines brought together leading voices in health care and public health for an afternoon of conversation and inspiration. For the first time, these exceptional individuals, who have been paramount in the effort to combat COVID-19 over the past 18 months, were together on one virtual stage. This event allowed our community the opportunity to directly engage with those on the frontlines of this pandemic, and to hear their personal stories of perseverance in the face of great challenge.
In this briefing, experts overviewed demographics of the Native American population in the United States as well as the current policy and regulatory landscape that guides and directs Native American health care infrastructure.
In this briefing, experts overviewed what comprises the field of environmental health and its corresponding policy, outlined the major players at the state and federal level, and highlighted immediate policy opportunities. Panelists also discussed how health disparities and inequities are tied to environmental factors and offered thoughts on how to close policy gaps.
In this briefing, experts overviewed the specific health and access challenges faced by people experiencing homelessness. Panelists also offered insights on how to deliver effective health care to this population, with a specific focus on barriers to access and potential policy strategies to alleviate these barriers.
During this exclusive on-the-record briefing for reporters, Admiral Rachel L. Levine, M.D., Assistant Secretary for Health at the U.S. Department of Health and Human Services, provided some opening remarks and responded to audience questions.
This 3-hour summit convened and informed health policy and oncology research communities about critical issues related to patient-centered cancer care and offered lessons, strategies, and policy approaches for the short and long term.
This briefing will examine the difference between perinatal health and perinatal mental health and their intrinsic relationship. Panelists will delve into factors contributing to perinatal health and mental health as well as policy levers and promising solutions available to stakeholders to reduce and prevent mental health symptoms and mood disorders.
Dr. Meena Seshamani, M.D., Ph.D. director of the Center for Medicare and deputy administrator of the Centers for Medicare and Medicaid Services at the U.S. Department of Health and Human Services, will provide some opening remarks and respond to audience questions.
This briefing provided a primer on health data, how we use it, and how we process it. Attendees learned the challenges of leveraging health data for decision-making and the implications for providers, payers, and patients during the COVID-19 pandemic.
In this session exclusively for journalists, expert panelists explored the tension between the affordability of prescription drugs and the need to preserve advances in biomedical innovation.
Elizabeth Fowler, J.D., Ph.D., director of the Center for Medicare and Medicaid Innovation (CMMI) and deputy administrator of the Centers for Medicare and Medicaid Services at the U.S. Department of Health and Human Services, provided some opening remarks and responded to audience questions.